No black box warning on record for Lidoderm

As of the latest FDA labeling reviewed, Lidoderm (LIDOCAINE PATCH 5%) does not carry a black box warning. Standard warnings and precautions still apply — see the full Lidoderm medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Risk of Methemoglobinemia Cases of methemoglobinemia have been reported in association with local anesthetic use. Although all patients are at risk for methemoglobinemia, patients with glucose-6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, infants under 6 months of age, and concurrent exposure to oxidizing agents or their

No black box warning on record for Lidoderm

Other warnings & precautions

WARNINGS Risk of Methemoglobinemia Cases of methemoglobinemia have been reported in association with local anesthetic use. Although all patients are at risk for methemoglobinemia, patients with glucose-6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, infants under 6 months of age, and concurrent exposure to oxidizing agents or their

Lidoderm Black Box Warning

No black box warning on record for Lidoderm

Other warnings & precautions

Lidoderm Black Box Warning

No black box warning on record for Lidoderm

Other warnings & precautions